Bruix, Jordi

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 6.

Journal Article

Muñoz-Martínez, Sergio; Sapena, Victor; Forner, Alejandro; Bruix, Jordi; Sanduzzi-Zamparelli, Marco; Ríos, José; Bouattour, Mohamed; El Kassas, Mohamed; Leal, Cassia Regina Guedes; Mocan, Tudor; Nault, Jean-Charles; Alves, Rogerio Camargo Pinheiro; Reeves, Helen L; da Fonseca, Leonardo; García-Juárez, Ignacio; Pinato, David J; Varela, María; Alqahtani, Saleh A; Alvares-da-Silva, Mario Reis; Bandi, Juan C; ... (2022). Outcome of liver cancer patients with SARS-CoV-2 infection. Liver international, 42(8), pp. 1891-1901. Wiley 10.1111/liv.15320

Sapena, Victor; Enea, Marco; Torres, Ferran; Celsa, Ciro; Rios, Jose; Rizzo, Giacomo Emanuele Maria; Nahon, Pierre; Mariño, Zoe; Tateishi, Ryosuke; Minami, Tatsuya; Sangiovanni, Angelo; Forns, Xavier; Toyoda, Hidenori; Brillanti, Stefano; Conti, Fabio; Degasperi, Elisabetta; Yu, Ming-Lung; Tsai, Pei-Chien; Jean, Kevin; El Kassas, Mohamed; ... (2022). Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut, 71(3), pp. 593-604. BMJ Publishing Group 10.1136/gutjnl-2020-323663

Muñoz-Martínez, Sergio; Sapena, Victor; Forner, Alejandro; Nault, Jean-Charles; Sapisochin, Gonzalo; Rimassa, Lorenza; Sangro, Bruno; Bruix, Jordi; Sanduzzi-Zamparelli, Marco; Hołówko, Wacław; El Kassas, Mohamed; Mocan, Tudor; Bouattour, Mohamed; Merle, Philippe; Hoogwater, Frederik J H; Alqahtani, Saleh A; Reeves, Helen L; Pinato, David J; Giorgakis, Emmanouil; Meyer, Tim; ... (2021). Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP reports, 3(3), p. 100260. Elsevier 10.1016/j.jhepr.2021.100260

Gerbes, Alexander; Zoulim, Fabien; Tilg, Herbert; Dufour, Jean-François; Bruix, Jordi; Paradis, Valérie; Salem, Riad; Peck-Radosavljevic, Markus; Galle, Peter R; Greten, Tim F; Nault, Jean-Charles; Avila, Matias A (2018). Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut, 67(2), pp. 380-388. BMJ Publishing Group 10.1136/gutjnl-2017-315068

Bruix, Jordi; Tak, Won-Young; Gasbarrini, Antonio; Santoro, Armando; Colombo, Massimo; Lim, Ho-Yeong; Mazzaferro, Vincenzo; Wiest, Reiner; Reig, María; Wagner, Andrea; Bolondi, Luigi (2013). Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: Multicentre, open-label, phase II safety study. European journal of cancer, 49(16), pp. 3412-3419. Elsevier 10.1016/j.ejca.2013.05.028

Llovet, Josep M; Peña, Carol E A; Lathia, Chetan D; Shan, Michael; Meinhardt, Gerold; Bruix, Jordi (2012). Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clinical cancer research, 18(8), pp. 2290-300. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-11-2175

This list was generated on Sat May 4 13:15:05 2024 CEST.
Provide Feedback